✦ LIBER ✦

575 Retreatment with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in pegylated interferon α-2b (12KD)/ribavirin non-responders with cirrhosis/advanced fibrosis: Repeat interim analysis

✍ Scribed by N. Gitlin; D. Jensen; A. Di Bisceglie; T. Berg; J. Salmeron; M. Rizzetto; C. Yurdaydin; P. Marcellin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

583 Safety of peginterferon α-2a (40KD)

✍ D. Jensen; F. Andreone; Y. Benhamou; Y. Horsmans; M. Diago; A. Olveira Martins; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 234 KB

11 Efficacy of standard-dose and fixed-d

✍ P. Marcellin; G. Teuber; V. Canva; O. Weiland; A. Di Bisceglie; C. Brandao-Mello 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

P.259 Retreatment with peginterferon alp

✍ P. Marcellin; G. Teuber; B. Freilich; O. Weiland; A. Di Bisceglie; C. Brandao-Me 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 119 KB

582 High response rates with peginter-fe

✍ N. Izumi; S. Iino; T. Okuno; M. Omata; K. Kiyosawa; H. Kumada; N. Hayashi; G. Ya 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB